The independent source for health policy research, polling, and news.
6,461-6,480 of 112,947 results
Under increased scrutiny from the White House, state Medicaid officials are trying harder to prevent eligible people from losing coverage. One of the biggest challenges is simply finding them, and states are having to get more creative in their efforts.
The Washington Post reported that officials with America’s eight biggest pharmacy giants — Walgreens Boots Alliance, CVS, Walmart, Rite Aid, Kroger, Cigna, Optum Rx, and Amazon Pharmacy — told congressional investigators they required only a subpoena to share the records. Investigators began probing the practice in the aftermath of the Dobbs abortion decision.
The Lower Costs More Transparency Act of 2023, passed by the House 320-71 on Monday, would institute new transparency and pricing rules on PBMs and hospitals, and spare hospitals from some funding cuts while likely imposing others. The measure is unlikely to pass the Senate as currently written but signals bipartisan openness to the policies.
Today's early morning highlights from the major news organizations.
Contract negotiations between Adventist Health and Blue Shield of California fell through last week, and now the San Francisco Chronicle is warning thousands of Californians may have to pay out-of-network medical costs at their nearest hospital.
The issue stems from seniors being offered medical supplies they don't need, and then finding themselves stuck with the bill. Also in state health news: the Ozempic side effects lawsuit; CAR-T helping autoimmune patients; rising sales of antibiotics for food animals; and more.
After the UNLV shooting, President Joe Biden on Friday stepped up his demands for action against gun violence. USA Today covers college professors calling the issue a "national menace." Meanwhile, Wyoming Public Radio reports on how stigma prevents gun owners from seeking mental health help.
The disease is spread by infected brown dog ticks. Other news is on a continuing outbreak of salmonella spread through cantaloupe, and chronic wasting disease.
Amid rising RSV, Minnesota's first death for this season was tragically young. Meanwhile, in California, Riverside County officials reported two flu-related deaths, and L.A. County reported one. Separately, researchers are making progress toward treating long covid symptoms.
Supreme Court justices were expected to discuss on Friday whether to hear a case that would counter or uphold federal approval of the abortion pill mifepristone. If the court fails to take up the appeals, a lower court decision to limit the availability of the drug by mail would go into effect.
The FDA authorized on Friday a pair of gene therapies for sickle cell disease, one of which is the first to gain such approval using the CRISPR gene-editing system. News outlets report on costs and paths to patients for the treatments.
Unenthusiastic stakeholders and a lack of progress in negotiations over price and other financial matters have led Cigna Group to give up on the idea of combining with Humana, The Wall Street Journal reports.
Editorial writers discuss the RSV vaccine, sickle cell treatment, long covid and more.
Today's early morning highlights from the major news organizations.
Editorial writers discuss formaldehyde in hair relaxers, artificial intelligence in health care, drug pricing, and more.
Anti-gun activists from Connecticut and elsewhere visited lawmakers on Capitol Hill this week to again push for gun reforms. Next Thursday, Dec. 14, marks the 11th anniversary of the massacre at Sandy Hook Elementary in Newtown, Connecticut, that left 26 people dead, most of them children.
Each week, KFF Health News finds longer stories for you to enjoy. This week's selections include stories on cancer, phages, homelessness, mental health, and more.
CHWs, as they're known, are trained public health professionals. The new benefit goes into effect Jan. 1. Other state health news is on California's statewide minimum wage for health care workers, an investigation of a New York hospital's weight-loss surgery rates, Ohio's new marijuana law, and more.
The treatment, called exa-cel, would be the first approved medicine in the U.S. to use the gene-editing tool to alter DNA. In other pharma news, an unusual surge in stock trading before Abbvie's big announcement Wednesday has raised eyebrows.
This is not the first investigation into the issue. But Stat reports that the Senate Budget Committee probe encompasses hospitals in Rhode Island — home state of committee chair Sheldon Whitehouse, a Democrat — as well as hospitals in California, Pennsylvania, and elsewhere.
© 2026 KFF